Largest ever study of male breast cancer treatment shows more mastectomy, less radiation than in female disease

October 31, 2013 by Garth Sundem

University of Colorado Cancer Center researchers used data from 4,276 cases of male breast cancer and 718,587 cases of female breast cancer to show that the disease is treated differently in men than in women. Specifically, male breast cancer is treated with mastectomy more often than female breast cancer, and in cases in which locally advanced female breast cancer is commonly treated with radiation, the treatment is less used in the male disease.

"We know very little about male breast cancer since it comprises only 0.6 percent of all breast cancer, and nearly all therapy is based on female breast cancer studies. This study demonstrates that just as in , men with early stage breast cancer have the same outcome with a or a lumpectomy followed by radiation. In women, breast-conserving surgery is the standard and preferred treatment for the majority of women. Still, 87 percent of men in this study, compared to only 38 percent of women during the same time period, underwent mastectomy for early stage disease," says Rachel Rabinovitch, MD, investigator at the CU Cancer Center and professor of Radiation Oncology at the University of Colorado School of Medicine.

"Traditionally, breast conservation is not even considered for men with breast cancer. But in a world in which a man's appearance is increasingly important, and where it is common for men to be seen without a shirt in the gym or on the beach, mastectomy can have overlooked psycho-sexual impacts on men, just as in women," Rabinovitch says.

The group's data comes from the US Surveillance, Epidemiology and End Results (SEER) Program database, which has collected cancer statistics since 1973 and includes tumor type, demographics, treatment and outcome information for about 28 percent of the U.S. population.

"Because male breast cancer is a rare disease, it isn't studied prospectively – it is very challenging to enroll enough patients in a trial evaluating therapy for male breast cancer. To learn about the disease from large patient groups, we have to look back through collected data, like that in SEER. So the question becomes what can you learn from these numbers? What can you find that's useful, practical, new and interesting?" Rabinovitch says.

The study also shows that whereas mastectomy may be over-used in , radiation therapy may be under-utilized. In locally advanced the disease is comprised of a large tumor mass or has spread to the surrounding chest wall, nearby skin or underarm lymph nodes but not yet to other organs. In the current study, 34 percent of males with locally advanced disease were treated with therapy following mastectomy, compared with 45 percent of females with similar disease.

"I think these findings point to new areas of research and should push clinicians to consider the advantages of breast conserving therapy with their patients. It's a new conversation – surgeons and oncologists shouldn't assume that are fine with a mastectomy," Rabinovitch says.

Explore further: Growing use of MRIs leading to more invasive breast cancer surgery

More information: www.ncbi.nlm.nih.gov/pubmed/24138917

Related Stories

Growing use of MRIs leading to more invasive breast cancer surgery

August 14, 2013
Heavy use of magnetic resonance imaging (MRI) may be leading to unnecessary breast removal in older women with breast cancer, according to a study by Yale School of Medicine researchers in the current issue of Breast Cancer ...

Young breast cancer patients often opt for mastectomy

May 30, 2013
A new study of young women with breast cancer has found that most chose to have a mastectomy rather than a surgical procedure that would conserve the breast, researchers will report at the 49th Annual Meeting of the American ...

Better survival rates seen with lumpectomy compared with mastectomy for early breast cancer

January 28, 2013
A new analysis has found that lumpectomy plus radiation for early breast cancer may provide patients with a better chance of survival than mastectomy. Published early online in Cancer, a peer-reviewed journal of the American ...

External beam RT for early-stage breast cancer does not increase mortality risks

September 24, 2013
Early-stage breast cancer patients who receive external beam therapy (XRT) are not at higher risk for serious long-term side effects in the chest area, including increase in deaths from cardiac disease and secondary malignancies, ...

Radiation after lumpectomy helps prevent need for mastectomy in early stage breast cancer

August 13, 2012
Contrary to clinical recommendations, older women with early stage breast cancer may want to undergo radiation after lumpectomy to help ensure that they will not need a mastectomy in the future. That is the conclusion of ...

Rural women less likely to get radiation therapy after lumpectomy for breast cancer

June 24, 2013
Rural women with breast cancer are less likely than their urban counterparts to receive recommended radiation therapy after having a lumpectomy, a breast-sparing surgery that removes only tumors and surrounding tissue, a ...

Recommended for you

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.